Pre-earnings brief
Reports
Wed, Oct 28, 2026
Est. EPS
$0.21
Est. revenue
$1.6B
Implied move
±13.1%
EPS beat rate
63%
Avantor, Inc. is a global provider of mission-critical products and services to customers in the life sciences and advanced technology sectors. Operating within the health care sector, Avantor plays a vital role in supporting research and development, particularly in areas like pharmaceuticals and biotechnology.
Last quarter
In Q2 2026, Avantor reported an EPS of $0.21, exceeding expectations by 10.53%. The stock reacted positively, gaining 15.78% the following day.
Management promises and guidance
EPS beat streak
3Q
EPS beat rate
63%
Avg EPS surprise
+2.66%
Avg 1-day reaction
-8.57%
Analysts are cautiously optimistic about Avantor's upcoming earnings, expecting it to meet or slightly exceed the consensus EPS of $0.21 and revenue of $1.6B.
Bull case
If Avantor can deliver strong revenue growth and maintain or improve its profit margins, it could signal robust demand in the life sciences sector, leading to a positive stock reaction.
Bear case
Conversely, if the company fails to meet earnings expectations or provides weak guidance, it may raise concerns about its growth trajectory, potentially leading to a negative market response.
Key metrics to watch
Earnings Per Share (EPS)
$0.21EPS is a key measure of a company's profitability and will indicate how well Avantor is managing its costs and generating income.
Revenue
$1.6BRevenue growth is crucial for assessing the company's ability to expand its market presence and meet customer demand.
The print will turn on these.
Q1
Will Avantor's revenue growth meet or exceed the consensus estimate of $1.6B?
Revenue performance is critical for assessing the company's market position and growth potential, especially in a competitive sector.
Q2
Can Avantor maintain its EPS at or above the consensus of $0.21?
EPS is a direct indicator of profitability and efficiency, and any deviation could impact investor confidence.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±10.3%
Why consensus could be wrong
The consensus may underestimate Avantor's ability to capitalize on emerging trends in life sciences, particularly if they can demonstrate strong demand for their products.
Supporting evidence
The recent positive EPS surprises indicate improving operational efficiency.
Options pricing suggests a lower expected move compared to historical averages, indicating potential for a larger reaction.
The company's commitment to expanding its product offerings may not be fully reflected in current estimates.
Key risk
If Avantor shows strong demand signals in its revenue report, it could challenge the current consensus expectations.
Pre-commit to what would confirm each case.
This quarter's performance will hinge on Avantor's ability to deliver on revenue and profit expectations amidst a challenging market landscape.
Bull confirmed if
Achieving revenue growth of at least $1.6B while maintaining an EPS of $0.21 or higher would confirm the bullish outlook.
Bear confirmed if
Falling short of the $1.6B revenue target or reporting an EPS below $0.21 would validate the bearish concerns.
What the market is pricing for the move.
Implied Move
±10.01%
Historical Avg
±12.51%
The options market is pricing in a significant move of about 10% in either direction, indicating uncertainty about the earnings report.
Options are pricing a 10% move, while the stock has averaged a 12.51% move historically, suggesting a cheaper setup.
ATM IV
0.5%
30d HV
30.4%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options cheap in Health Care
Fade rate: 11 of 30 (37%)
This setup has occurred 30 times across Health Care in the last 2 years. 19 of 30 (63%) held or extended their move within 5 days — this setup typically holds direction. The average absolute 1-day move is 3.7%, with a raw directional average of -0.1% (roughly flat historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
105.41%
of float
Insider
1.53%
of float
Holders
603
institutions
Top Holders· as of Jun 2026
Dodge & Cox Inc.
120,020,974 sh · $1.8B
17.75%
0.3%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Avantor beats expectations, history suggests the stock could see an average one-day move of around +3.1%, reaffirming confidence in its growth strategy.
In line / cautious
If results are in line with expectations, the stock may experience a muted reaction, reflecting cautious sentiment from investors.
Miss
Should the company miss its targets, history suggests a potential drop of around -18.42%, indicating significant market disappointment.
The lines on the call that would change the story.
Blackrock Inc.
70,281,231 sh · $1.1B
10.39%
7.0%
Vanguard Portfolio Management LLC
31,343,250 sh · $481.1M
4.63%
0.2%
Vanguard Capital Management LLC
30,802,835 sh · $472.8M
4.55%
0.6%
Greenhaven Associates, Inc.
24,637,310 sh · $378.2M
3.64%
9.0%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.